Clinical Trial Update: Measurement of Serum Inflammatory Markers in Patients Treatment-resistant Depression Given Psilocybin

View source ↗

Summary

A clinical trial update from King's College London evaluating changes in serum inflammatory markers in adults with treatment-resistant major depressive disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: King's College London | Conditions: Depression - Major Depressive Disorder | Status: ACTIVE_NOT_RECRUITING